FDA Approves Leqembi: What You Should Know
FDA just approved Leqembi, a drug to slow the cognitive decline of Alzheimer’s patients, and Medicare has agreed to pay for it. Is it time for patients, families and physicians to be excited? Or do we need to temper our hopes?
ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.
GET IN TOUCH
Become a CareTalk sponsor
Guest appearance requests
Visit us on the web
FOLLOW CARETALK
Spotify
Apple Podcasts
Google Podcasts
Follow us on LinkedIn
#leqembi #alzheimers #pharma #FDA #medicare #medicaid #aduhelm
Subscribe to the CareTalk Newsletter to access exclusive content and insights covering the biggest topics in healthcare today.
Check out the CareTalk Store for official merch!
CareTalk is produced by Grippi Media
